Study of HY-2003 for double chin reduction
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests a new medicine called HY-2003 to reduce extra fat under the chin (double chin). It is for adults who have moderate to severe submental fat and want to see if injections can help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe double chin as assessed by a doctor.
- You are between 18 and 65 years old.
- Your weight has been stable for at least 6 months.
- You have not had any surgery, liposuction, or injections in the chin or neck area before.
- You are not allergic to deoxycholic acid or anesthetics like lidocaine.
- You are willing to use effective birth control during and for 6 months after the study (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
This study tests an injection called STP705 to reduce fat under the chin. It may be a good option if you have moderate to severe chin fat and want a non-surgical treatment.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
Hear when a new Moderate or Severe Submental Fullness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.